Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Indaptus Therapeutics Inc (INDP)

Indaptus Therapeutics Inc (INDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Indaptus Therapeutics Inc 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 USA

https://indaptusrx.com Employees: 7 P: 646-427-2727

Sector:

Medical

Description:

Indaptus Therapeutics approach is based on the hypothesis which efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals. Indaptus Therapeutics, formerly known as Intec Parent Inc., is based in NEW YORK.

Key Statistics

Overview:

Market Capitalization, $K 4,641
Enterprise Value, $K -1,149
Shares Outstanding, K 1,751
Annual Sales, $ 0 K
Annual Net Income, $ -15,020 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,980 K
EBIT, $ -15,850 K
EBITDA, $ -15,850 K
60-Month Beta 1.02
% of Insider Shareholders 20.80%
% of Institutional Shareholders 7.06%
Float, K 1,387
% Float 79.20%
Short Interest 14
Short Float 0.80%
Short Volume Ratio 0.53

Growth:

1-Year Return -89.29%
3-Year Return -93.72%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 98.15%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -2.98 on 11/12/25
Next Earnings Date 03/12/26
Earnings Per Share ttm -31.67
EPS Growth vs. Prev Qtr 67.22%
EPS Growth vs. Prev Year 66.75%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-28 on 06/27/25

INDP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -697.13%
Return-on-Assets % -255.27%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.70
Book Value/Share 2.81
Interest Coverage -0.85
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar